175 related articles for article (PubMed ID: 38783023)
1. Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism.
Jekhmane S; Derks MGN; Maity S; Slingerland CJ; Tehrani KHME; Medeiros-Silva J; Charitou V; Ammerlaan D; Fetz C; Consoli NA; Cochrane RVK; Matheson EJ; van der Weijde M; Elenbaas BOW; Lavore F; Cox R; Lorent JH; Baldus M; Künzler M; Lelli M; Cochrane SA; Martin NI; Roos WH; Breukink E; Weingarth M
Nat Microbiol; 2024 Jul; 9(7):1778-1791. PubMed ID: 38783023
[TBL] [Abstract][Full Text] [Related]
2. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
Schneider T; Kruse T; Wimmer R; Wiedemann I; Sass V; Pag U; Jansen A; Nielsen AK; Mygind PH; Raventós DS; Neve S; Ravn B; Bonvin AM; De Maria L; Andersen AS; Gammelgaard LK; Sahl HG; Kristensen HH
Science; 2010 May; 328(5982):1168-72. PubMed ID: 20508130
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of teixobactins in cellular membranes.
Shukla R; Medeiros-Silva J; Parmar A; Vermeulen BJA; Das S; Paioni AL; Jekhmane S; Lorent J; Bonvin AMJJ; Baldus M; Lelli M; Veldhuizen EJA; Breukink E; Singh I; Weingarth M
Nat Commun; 2020 Jun; 11(1):2848. PubMed ID: 32503964
[TBL] [Abstract][Full Text] [Related]
4. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
5. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
Grein F; Schneider T; Sahl HG
J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
[TBL] [Abstract][Full Text] [Related]
6. Lipid II as a target for antibiotics.
Breukink E; de Kruijff B
Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
[TBL] [Abstract][Full Text] [Related]
7. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
Münch D; Sahl HG
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
[TBL] [Abstract][Full Text] [Related]
8. Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II.
de Leeuw E; Li C; Zeng P; Li C; Diepeveen-de Buin M; Lu WY; Breukink E; Lu W
FEBS Lett; 2010 Apr; 584(8):1543-8. PubMed ID: 20214904
[TBL] [Abstract][Full Text] [Related]
9. Molecular Dynamics Simulations Reveal the Conformational Flexibility of Lipid II and Its Loose Association with the Defensin Plectasin in the Staphylococcus aureus Membrane.
Witzke S; Petersen M; Carpenter TS; Khalid S
Biochemistry; 2016 Jun; 55(23):3303-14. PubMed ID: 27158738
[TBL] [Abstract][Full Text] [Related]
10. Targeting extracellular pyrophosphates underpins the high selectivity of nisin.
Bonev BB; Breukink E; Swiezewska E; De Kruijff B; Watts A
FASEB J; 2004 Dec; 18(15):1862-9. PubMed ID: 15576489
[TBL] [Abstract][Full Text] [Related]
11. Targeting bactoprenol-coupled cell envelope precursors.
Ulm H; Schneider T
Appl Microbiol Biotechnol; 2016 Sep; 100(18):7815-25. PubMed ID: 27495122
[TBL] [Abstract][Full Text] [Related]
12. Towards the Native Binding Modes of Antibiotics that Target Lipid II.
Medeiros-Silva J; Jekhmane S; Breukink E; Weingarth M
Chembiochem; 2019 Jul; 20(14):1731-1738. PubMed ID: 30725496
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
[TBL] [Abstract][Full Text] [Related]
14. Effect of the peptide moiety of Lipid II on bacterial transglycosylase.
Shih HW; Chang YF; Li WJ; Meng FC; Huang CY; Ma C; Cheng TJ; Wong CH; Cheng WC
Angew Chem Int Ed Engl; 2012 Oct; 51(40):10123-6. PubMed ID: 22952114
[No Abstract] [Full Text] [Related]
15. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
[TBL] [Abstract][Full Text] [Related]
16. New Found Hope for Antibiotic Discovery: Lipid II Inhibitors.
Ng V; Chan WC
Chemistry; 2016 Aug; 22(36):12606-16. PubMed ID: 27388768
[TBL] [Abstract][Full Text] [Related]
17. Structural Insights into the Mode of Action of the Peptide Antibiotic Copsin.
Franzoi M; van Heuvel Y; Thomann S; Schürch N; Kallio PT; Venier P; Essig A
Biochemistry; 2017 Sep; 56(37):4992-5001. PubMed ID: 28825809
[TBL] [Abstract][Full Text] [Related]
18. Substrate analogues to study cell-wall biosynthesis and its inhibition.
Lazar K; Walker S
Curr Opin Chem Biol; 2002 Dec; 6(6):786-93. PubMed ID: 12470732
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial mechanism of lantibiotics.
Islam MR; Nagao J; Zendo T; Sonomoto K
Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
